Ultragenyx to Highlight Pipeline at Analyst and Investor Day on December 4
30 nov. 2017 08h30 HE
|
Ultragenyx Pharmaceutical Inc.
NOVATO, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare...